Graphene oxide, a key graphene form, showed no short-term lung/cardiovascular harm in a clinical trial, potentially simplifying its use in tech, engineering.

Graphene, a revolutionary and highly sought-after material, has demonstrated no short-term adverse effects on lung or cardiovascular function. Researchers conducted a controlled exposure clinical trial using ultra-pure graphene oxide, a water-compatible form of the material. This marks a significant step towards practical uses of graphene, which could have applications in tissue engineering and technological device development.

February 16, 2024
6 Articles

Further Reading